Literature DB >> 21816748

Potential withdrawal of bevacizumab for the treatment of breast cancer.

Alison Jones, Paul Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21816748     DOI： 10.1136/bmj.d4946

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  The value of progression-free survival to patients with advanced-stage cancer.

Authors:  Lesley J Fallowfield; Anne Fleissig
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

2.  Active roles of tumor stroma in breast cancer metastasis.

Authors:  Zahraa I Khamis; Ziad J Sahab; Qing-Xiang Amy Sang
Journal:  Int J Breast Cancer       Date:  2012-02-19

3.  The Roles of the Learned Societies in Improving Quality of Life in the context of Globalisation.

Authors:  Michael Baum
Journal:  Ann Med Surg (Lond)       Date:  2012-08-10

4.  Comment on 'The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer'.

Authors:  D Kitchen; M O'Brien; B Hughes; I Gill; S Rumbles; P Ellis; J Stebbing
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.